Sanjivani Paranteral Ltd. benchmarking: Performance to industry peers

Financial

	Sanjivani Paranteral	Astonea Labs	Auro Laboratories
Operational Metrics
Pharmaceuticals
Quarterly Sales Volume - Injectables	n/a	n/a	n/a
Quarterly Sales Volume - Orals	n/a	n/a	n/a
Quarterly Sales Volume - Nutraceuticals	n/a	n/a	n/a
Financials
5 yr Average ROE	14.47 %	18.71 %	12.83 %
5yr average Equity Multiplier	-1.07	6.86	1.84
5yr Average Asset Turnover Ratio	1.28	0.89	0.8
5yr Avg Net Profit Margin	11.86 %	3.1 %	9.49 %
Price to Book	4.24	0.0	3.88
P/E	23.01	31.35	57.33
5yr Avg Cash Conversion Cycle	9.84 Days	85.07 Days	80.24 Days
Inventory Days	50.77 Days	86.76 Days	56.39 Days
Days Receivable	53.66 Days	118.45 Days	214.37 Days
Days Payable	138.53 Days	163.78 Days	115.48 Days
5yr Average Interest Coverage Ratio	21.37	2.12	10.53
5yr Avg ROCE	-90.78 %	18.06 %	16.02 %
5yr Avg Operating Profit Margin	14.73 %	15.14 %	15.11 %
5 yr average Debt to Equity	-0.19	3.71	0.48
5yr CAGR Net Profit	12.42 %	84.54 %	-23.84 %
5yr Average Return on Assets	15.34 %	2.92 %	7.53 %
Shareholdings
Promoter Holding	31.2 %	72.3 %	52.18 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	3.85 %	0.0	0.09 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Sanjivani Paranteral	Astonea Labs	Auro Laboratories
Product Wise Break-Up	Product Wise Break-Up Injectables 50.0 Tablets 42.6 Nutraceuticals 7.4 Cosmetics 0 Drugs 0	Product Wise Break-Up Cosmetics 23.47 Drugs 76.53 Injectables 0 Nutraceuticals 0 Tablets 0	Product Wise Break-Up Cosmetics 0 Drugs 0 Injectables 0 Nutraceuticals 0 Tablets 0 Others 100
Location Wise Break-Up	Location Wise Break-Up Middle East & Africa 41.2 Latin America 29.4 India 28.0 CIS Countries 1.4	-	-